5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report

Introduction: Drug-induced liver injury (DILI) associated with 5-aminosalicylic acid (5-ASA) is a rare but potentially life-threatening adverse event. Case Presentation: We report the case of a 58-year-old woman with ulcerative colitis who developed DILI after initiating maintenance therapy with the...

Full description

Bibliographic Details
Main Authors: Asuka Watanabe, Tsutomu Nishida, Naoto Osugi, Takao Kitanaka, Yutaro Minoura, Satoru Okabe, Naohiro Sakamoto, Yoshifumi Fujii, Aya Sugimoto, Dai Nakamatsu, Kengo Matsumoto, Masashi Yamamoto, Shiro Adachi, Koji Fukui
Format: Article
Language:English
Published: Karger Publishers 2024-01-01
Series:Case Reports in Gastroenterology
Subjects:
Online Access:https://beta.karger.com/Article/FullText/536097
_version_ 1797291574504194048
author Asuka Watanabe
Tsutomu Nishida
Naoto Osugi
Takao Kitanaka
Yutaro Minoura
Satoru Okabe
Naohiro Sakamoto
Yoshifumi Fujii
Aya Sugimoto
Dai Nakamatsu
Kengo Matsumoto
Masashi Yamamoto
Shiro Adachi
Koji Fukui
author_facet Asuka Watanabe
Tsutomu Nishida
Naoto Osugi
Takao Kitanaka
Yutaro Minoura
Satoru Okabe
Naohiro Sakamoto
Yoshifumi Fujii
Aya Sugimoto
Dai Nakamatsu
Kengo Matsumoto
Masashi Yamamoto
Shiro Adachi
Koji Fukui
author_sort Asuka Watanabe
collection DOAJ
description Introduction: Drug-induced liver injury (DILI) associated with 5-aminosalicylic acid (5-ASA) is a rare but potentially life-threatening adverse event. Case Presentation: We report the case of a 58-year-old woman with ulcerative colitis who developed DILI after initiating maintenance therapy with the multimatrix system 5-ASA. The patient presented with grade 4 liver enzyme elevation on day 98 after initiating 5-ASA and was admitted to the hospital. Blood tests revealed the mixed liver injury, and imaging studies showed no abnormalities except for mild lymph node enlargement. Liver biopsy revealed acute lobular hepatitis with interfacial activity. The patient’s score on the International Autoimmune Hepatitis Group 1999 revised scoring system was a total score of 10, causing a suspicion for the diagnosis of autoimmune hepatitis. The DDW-J 2004 scale calculated a total score of six, indicating a high probability of DILI. We suspected DILI due to 5-ASA, and the 5-ASA formulations were discontinued. The patient was treated with ursodeoxycholic acid and neominophagen C, and her liver function gradually improved without steroid treatment. Finally, we definitively diagnosed DILI based on the pathological findings and clinical course after discontinuation of 5-ASA. Conclusion: This case highlights the importance of monitoring liver function in patients receiving 5-ASA therapy.
first_indexed 2024-03-07T19:39:28Z
format Article
id doaj.art-866bd9910828445a93e4eed649a329ae
institution Directory Open Access Journal
issn 1662-0631
language English
last_indexed 2024-03-07T19:39:28Z
publishDate 2024-01-01
publisher Karger Publishers
record_format Article
series Case Reports in Gastroenterology
spelling doaj.art-866bd9910828445a93e4eed649a329ae2024-02-29T07:06:18ZengKarger PublishersCase Reports in Gastroenterology1662-06312024-01-01181394810.1159/0005360975360975-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case ReportAsuka Watanabe0Tsutomu Nishida1Naoto Osugi2Takao Kitanaka3Yutaro Minoura4Satoru Okabe5Naohiro Sakamoto6Yoshifumi Fujii7Aya Sugimoto8Dai Nakamatsu9Kengo Matsumoto10Masashi Yamamoto11Shiro Adachi12Koji Fukui13Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Pathology, Toyonaka Municipal Hospital, Toyonaka, JapanDepartment of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanIntroduction: Drug-induced liver injury (DILI) associated with 5-aminosalicylic acid (5-ASA) is a rare but potentially life-threatening adverse event. Case Presentation: We report the case of a 58-year-old woman with ulcerative colitis who developed DILI after initiating maintenance therapy with the multimatrix system 5-ASA. The patient presented with grade 4 liver enzyme elevation on day 98 after initiating 5-ASA and was admitted to the hospital. Blood tests revealed the mixed liver injury, and imaging studies showed no abnormalities except for mild lymph node enlargement. Liver biopsy revealed acute lobular hepatitis with interfacial activity. The patient’s score on the International Autoimmune Hepatitis Group 1999 revised scoring system was a total score of 10, causing a suspicion for the diagnosis of autoimmune hepatitis. The DDW-J 2004 scale calculated a total score of six, indicating a high probability of DILI. We suspected DILI due to 5-ASA, and the 5-ASA formulations were discontinued. The patient was treated with ursodeoxycholic acid and neominophagen C, and her liver function gradually improved without steroid treatment. Finally, we definitively diagnosed DILI based on the pathological findings and clinical course after discontinuation of 5-ASA. Conclusion: This case highlights the importance of monitoring liver function in patients receiving 5-ASA therapy.https://beta.karger.com/Article/FullText/5360975-aminosalicylic aciddrug-induced liver injuryulcerative colitisliver biopsyinterface hepatitis
spellingShingle Asuka Watanabe
Tsutomu Nishida
Naoto Osugi
Takao Kitanaka
Yutaro Minoura
Satoru Okabe
Naohiro Sakamoto
Yoshifumi Fujii
Aya Sugimoto
Dai Nakamatsu
Kengo Matsumoto
Masashi Yamamoto
Shiro Adachi
Koji Fukui
5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report
Case Reports in Gastroenterology
5-aminosalicylic acid
drug-induced liver injury
ulcerative colitis
liver biopsy
interface hepatitis
title 5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report
title_full 5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report
title_fullStr 5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report
title_full_unstemmed 5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report
title_short 5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report
title_sort 5 aminosalicylic acid induced liver injury in a patient with ulcerative colitis a case report
topic 5-aminosalicylic acid
drug-induced liver injury
ulcerative colitis
liver biopsy
interface hepatitis
url https://beta.karger.com/Article/FullText/536097
work_keys_str_mv AT asukawatanabe 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT tsutomunishida 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT naotoosugi 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT takaokitanaka 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT yutarominoura 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT satoruokabe 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT naohirosakamoto 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT yoshifumifujii 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT ayasugimoto 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT dainakamatsu 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT kengomatsumoto 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT masashiyamamoto 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT shiroadachi 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport
AT kojifukui 5aminosalicylicacidinducedliverinjuryinapatientwithulcerativecolitisacasereport